Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
New
Closed
Net new
Funds Holding
2,556
Funds Holding Change
-5
Funds Holding Growth
-0.2%
Value
$927B
Holding in Top 10
1,214
Top 10 Change
+86
Top 10 Growth
+8%
Value Growth
+6%
New
69
Increased
1,131
Reduced
1,204
Closed
54
Capital Inflow
$25.6B
Capital Outflow
$37B
Net Capital Flow
-$11.4B
Capital Flow Change
-$12B
Calls
$12.4B
Puts
$12.9B
Net Calls
-$480M
Put/Call Ratio
1.04